Baxion
Screening
Tags
Alerts
Theme
Rhythm Pharmaceuticals, Inc.
RYTM
·
NASDAQ
·
$89.82
Share Price as of 11/2
·
$6B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/04/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
02/26/26
10-Q
Q3 ended 09/30/25
11/04/25
10-Q
Q2 ended 06/30/25
08/05/25
Disclosures
Filter
8-K
Current report
08/04/26
8-K
Current report
06/25/26
8-K
Current report
06/15/26
8-K
Current report
05/05/26
8-K
Current report
04/03/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
05/05/26
S-3ASR
Automatic shelf registration
02/26/26
S-8
Registration of securities for employees
02/26/26
S-8
Registration of securities for employees
01/16/26
424B5
Prospectus supplement
07/10/25
Proxies
Filter
DEFA14A
Additional proxy materials
05/29/26
DEFA14A
Additional proxy materials
05/05/26
DEF 14A
Definitive proxy
04/29/26
DEF 14A
Definitive proxy
04/29/25
DEFA14A
Additional proxy materials
04/29/25
Ownership
Filter
SC 13G
Beneficial ownership
10/13/26
144
Proposed sale of securities
09/14/26
Form 4
Insider transaction
09/14/26
Form 4
Insider transaction
09/01/26
144
Proposed sale of securities
08/31/26
Other
Filter
ARS
Annual report to shareholders
04/29/26
ARS
Annual report to shareholders
04/29/25
ARS
Annual report to shareholders
04/26/24
ARS
Annual report to shareholders
04/27/23
EFFECT
Request for effectiveness
11/15/21
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/04/26
8-K
Current report
08/04/26
8-K
Current report
06/25/26
8-K
Current report
06/15/26
DEFA14A
Additional proxy materials
05/29/26
Ownership
Filter
SC 13G
Beneficial ownership
10/13/26
144
Proposed sale of securities
09/14/26
Form 4
Insider transaction
09/14/26
Form 4
Insider transaction
09/01/26
144
Proposed sale of securities
08/31/26